Hybio Pharmaceutical (300199) — Financial Flexibility Index
Hybio Pharmaceutical (300199) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥213.38 Million (operating CF CN¥117.78 Million minus capex CN¥95.60 Million) represents 0% of total liabilities (CN¥2.50 Billion). Also explore 300199 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hybio Pharmaceutical Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Hybio Pharmaceutical across 18 annual periods. Check 300199 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hybio Pharmaceutical (2007–2024)
Year-by-year free cash flow to debt coverage for Hybio Pharmaceutical. For the full company profile including market capitalisation, see 300199 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | CN¥280.54 Million | CN¥164.71 Million | CN¥2.41 Billion | ▲ +270.9% |
| 2023 | 0.03x | CN¥78.23 Million | CN¥-3.54 Million | CN¥2.49 Billion | ▼ -64.7% |
| 2022 | 0.09x | CN¥205.65 Million | CN¥15.81 Million | CN¥2.31 Billion | ▼ -43.6% |
| 2021 | 0.16x | CN¥355.83 Million | CN¥156.83 Million | CN¥2.26 Billion | ▲ +26.5% |
| 2020 | 0.12x | CN¥291.65 Million | CN¥47.99 Million | CN¥2.34 Billion | ▼ -54.0% |
| 2019 | 0.27x | CN¥674.79 Million | CN¥104.64 Million | CN¥2.49 Billion | ▲ +48.9% |
| 2018 | 0.18x | CN¥412.57 Million | CN¥47.00 Million | CN¥2.27 Billion | ▼ -40.9% |
| 2017 | 0.31x | CN¥434.88 Million | CN¥213.74 Million | CN¥1.41 Billion | ▼ -36.4% |
| 2016 | 0.48x | CN¥412.46 Million | CN¥296.41 Million | CN¥852.42 Million | ▼ -11.7% |
| 2015 | 0.55x | CN¥497.82 Million | CN¥138.84 Million | CN¥908.68 Million | ▼ -7.8% |
| 2014 | 0.59x | CN¥238.59 Million | CN¥153.43 Million | CN¥401.32 Million | ▼ -78.6% |
| 2013 | 2.77x | CN¥456.33 Million | CN¥153.48 Million | CN¥164.48 Million | ▼ -3.4% |
| 2012 | 2.87x | CN¥308.57 Million | CN¥87.19 Million | CN¥107.42 Million | ▲ +13.5% |
| 2011 | 2.53x | CN¥150.74 Million | CN¥72.48 Million | CN¥59.56 Million | ▲ +5.5% |
| 2010 | 2.40x | CN¥77.52 Million | CN¥54.69 Million | CN¥32.30 Million | ▲ +274.1% |
| 2009 | 0.64x | CN¥35.11 Million | CN¥26.11 Million | CN¥54.73 Million | ▼ -77.4% |
| 2008 | 2.84x | CN¥106.02 Million | CN¥45.75 Million | CN¥37.32 Million | ▼ -49.7% |
| 2007 | 5.65x | CN¥53.93 Million | CN¥49.04 Million | CN¥9.54 Million | — |